- Home
- LFCR vs DHF Comparison
LFCR vs DHF Comparison
Compare LFCR & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LFCR | DHF |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.9M | 162.2M |
| IPO Year | 1996 | 1998 |
Fundamental Metrics
Financial Performance| Metric | LFCR | DHF |
|---|---|---|
| Price | $6.54 | $2.22 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | 351.2K | ★ 356.5K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $557,559,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.92 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $3.63 | $2.12 |
| 52 Week High | $8.98 | $2.61 |
Technical Indicators
Market Signals| Indicator | LFCR | DHF |
|---|---|---|
| Relative Strength Index (RSI) | 79.37 | 36.99 |
| Support Level | $4.25 | $2.12 |
| Resistance Level | $8.40 | $2.42 |
| Average True Range (ATR) | 0.18 | 0.03 |
| MACD | 0.28 | -0.00 |
| Stochastic Oscillator | 97.13 | 61.11 |
Price Performance
Historical ComparisonAbout LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. The fund invests predominantly in fixed-income securities of below-investment-grade credit quality.